Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹46 Cr
P/E Ratio
15.54
P/B Ratio
4.66
Industry P/E
37.33
Debt to Equity
0.54
ROE
3.48 %
ROCE
9.72 %
Div. Yield
0 %
Book Value
13.3
EPS
3.99
CFO
₹6.17 Cr
EBITDA
₹-0.03 Cr
Net Profit
₹-2.69 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Gujarat Terce Lab
| -24.59 | -5.29 | -20.93 | -7.08 | 28.34 | 52.20 | 22.34 |
|
BSE Healthcare
| -5.16 | 1.70 | -0.71 | 23.86 | 20.19 | 23.02 | 9.90 |
|
BSE Small Cap
| -9.94 | 4.33 | -3.72 | 6.13 | 19.05 | 35.54 | 15.87 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
|
|---|---|---|---|---|---|
|
Gujarat Terce Lab
| 197.02 | 56.11 | 0.05 | 106.85 | 9.65 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 434.15 | 7,095.26 | 25.86 | 12.5 | |
| 5,258.50 | 8,712.93 | 36.83 | 43.77 | |
| 687.40 | 6,656.14 | 75.39 | 4.01 | |
| 689.20 | 6,139.88 | 22.78 | 12.68 |
No Review & Analysis are available.
Gujarat Terce Laboratories Limited manufactures and markets medical and pharmaceutical preparations in India. The company offers branded and generic formulations covering various therapeutic, such as antibiotics, respiratory, nutraceuticals,... gastrointestinal, anti-fungal, and others. It provides its products in various forms, such as tablets, capsules, oral liquids, injections, and ointments. The company also exports its products. Gujarat Terce Laboratories Limited was founded in 1985 and is based in Ahmedabad, India. Read more
Incorporated
1985
Chairman
Natwarbhai P Prajapati
Managing Director
Aalap Prajapati
Headquarters
Gandhinagar, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Gujarat Terce Laboratories Ltd stood at ₹ 25 Cr as on 31-Dec-24
The share price of Gujarat Terce Laboratories Ltd is ₹63.95 (BSE) as of 24-Apr-2025 09:55 IST. Gujarat Terce Laboratories Ltd has given a return of 28.34% in the last 3 years.
Gujarat Terce Laboratories Ltd has a market capitalisation of ₹ 46 Cr as on 23-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Gujarat Terce Laboratories Ltd is 4.66 times as on 23-Apr-2025, a 13% discount to its peers’ median range of 5.35 times.
The P/E ratio of Gujarat Terce Laboratories Ltd is 15.54 times as on 23-Apr-2025, a 58% discount to its peers’ median range of 37.33 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Gujarat Terce Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Gujarat Terce Laboratories Ltd.
Gujarat Terce Laboratories Limited manufactures and markets medical and pharmaceutical preparations in India. The company offers branded and generic formulations covering various therapeutic, such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and others. It provides its products in various forms, such as tablets, capsules, oral liquids, injections, and ointments. The company also exports its products. Gujarat Terce Laboratories Limited was founded in 1985 and is based in Ahmedabad, India.
The prominent promoters of Gujarat Terce Laboratories Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
ABUNDANT TRADE LINK PRIVATE LIMITED |
14.5%
|
|
AALAP NATUBHAI PRAJAPATI |
13.22%
|
|
NATWARBHAI PARSOTTAM PRAJAPATI |
8.57%
|
The chairman of the company is Natwarbhai P Prajapati, and the managing director is Aalap Prajapati.
There is no promoter pledging in Gujarat Terce Laboratories Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
8,680
|
|
|
7,005
|
|
|
6,570
|
|
|
6,016
|
| Gujarat Terce Laboratories Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
37.04
|
|
Operating margin(%)
|
6.91
|
|
Net Margin(%)
|
5.87
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Gujarat Terce Laboratories Ltd was ₹3 Cr.
₹2.02
(
